Back to search

Article

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis

2023-01-19

Abstract excerpt

<title>Abstract</title> <p>Background There are no approved noninvasive tests (NIT) for the diagnosis of nonalcoholic steatohepatitis (NASH) and its histological phenotypes. Methods The FNIH-NIMBLE consortium tested 5 serum-based NIT panels for the following intended uses: NIS4: At-risk NASH, a composite of NASH with NAFLD activity score (NAS) ≥ 4 and fibrosis stage ≥ 2, OWLiver: NASH and NAS ≥ 4, enhanced live...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa87fabc-cc35-5b45-9c60-37193f18c180
DOI
10.21203/rs.3.rs-2492725/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic SteatohepatitisDOI 10.21203/rs.3.rs-2492725/v1
Select a neighboring publication to make it the new centre.